InsiderTrades

Form 4 for RMD ResMed|

Accepted 2025-11-10 00:00:00 ET · period of report 2025-11-07 · accession 0000943819-25-000095 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-11-10 2025-11-07 RMD Farrell Michael J. COB, CEO, Dir M - OptEx $101.64 +8,011 468.8K +2% +$814.2K
D 2025-11-10 2025-11-07 RMD Farrell Michael J. COB, CEO, Dir S - Sale+OE $249.75 -8,011 467.9K -2% -$2.00M
DM 2025-11-10 2025-11-07 RMD Farrell Michael J. COB, CEO, Dir M - OptEx $0.00 -8,011 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common ResMed Common Stock 2025-11-07 M A 7,028 $101.64 475,877 D — —
2 Common ResMed Common Stock 2025-11-07 M A 983 $101.64 468,849 D — — (F2) Includes 74.3412 shares of ResMed stock purchased on October 31, 2025, through the ResMed Employee Stock Purchase Plan.
3 Common ResMed Common Stock 2025-11-07 S D 8,011 $249.75 467,866 D — — (F3) This transaction was executed in multiple trades at prices ranging from $248.13 - $251.46. The price reported above reflects the weighted average sale price.
4 Derivative ResMed Common Stock Options 2025-11-07 M D 983 $0.00 7,028 D $101.64 · 2019-11-11 to 2025-11-14 983 ResMed Common Stock (F4) Represents date options first become exercisable. Options vest 1/3 per year.
5 Derivative ResMed Common Stock Options 2025-11-07 M D 7,028 $0.00 0 D $101.64 · 2019-11-11 to 2025-11-14 7,028 ResMed Common Stock (F4) Represents date options first become exercisable. Options vest 1/3 per year.